AstraZeneca’s Profit Gains on Sales of Cancer Drugs

1d ago, source:

AstraZeneca Plc shares surged after the UK drugmaker reported profit that outpaced expectations, buoyed by demand for its ...

Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million

2d ago, source: Yahoo Finance

SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company ... for the ...

AstraZeneca Earnings, Sales Rise, Beat Forecasts

1d ago, source: Wall Street Journal on MSN

The Anglo-Swedish pharmaceutical giant said Thursday that its core earnings per share increased to $2.06 from $1.92 the prior ...

Sanders takes aim at US drug prices of Novo’s Ozempic and Wegovy

23h ago, source: Pharmaceutical Technology on MSN

A Senate Committee is investigating the “outrageously high” US price tags of the blockbuster diabetes and obesity drugs.

Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN) and BioMarin Pharmaceutical (BMRN)

11h ago, source:

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on AstraZeneca (AZN – Research Report) and ...

Incannex Healthcare Inc. Quarterly Update, Q1 2024

10d ago, source:

MELBOURNE, Australia, April 16, 2024 (GLOBE NEWSWIRE) -- Clinical stage pharmaceutical development company, Incannex Healthcare Inc. (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is pleased to ...

7 Old-School Blue-Chip Dividend Stocks Offer Total Return Magic

14d ago, source: 24/7 Wall St. on MSN

Investors love dividend stocks because they provide dependable income and a great opportunity for solid total return. Total ...

AstraZeneca's (AZN) Fasenra Gets FDA Nod for Asthma in Kids

14d ago, source: Zacks.com on MSN

AstraZeneca AZN announced that the FDA has approved its marketed asthma drug, Fasenra (benralizumab), for use in children.

Agios Pharmaceuticals gets grant for phenylketonuria treatment compound

8d ago, source: Pharmaceutical Technology

Discover the groundbreaking patent granted to Agios Pharmaceuticals Inc for compounds targeting specific mutations in phenylketonuria patients. Learn more about the innovative Formula I-B-1 compound ...

Pilots suspended after allowing passenger in cockpit mid-flight

7d ago, source:

Two United Airlines pilots have been suspended after the captain let an MLB baseball coach sit in the captain’s seat while ...

JonesTrading Initiates Coverage of Janux Therapeutics (JANX) with Buy Recommendation

10d ago, source:

As of March 31, 2024, the average one-year price target for Janux Therapeutics is 57.46. The forecasts range from a low of 25.25 to a high of $105.00. The average price target represents an increase ...

6 Ultimate Dividend Stocks for Long-Term Passive Income Growth

7d ago, source: 24/7 Wall St on MSN

Investors looking for long-term passive income should focus on six ultimate dividend winners that all pay big and dependable ...